Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
3.
J Dermatolog Treat ; 34(1): 2200570, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37026416

RESUMO

BACKGROUND: Topical medication is the mainstay for treatment of mild psoriasis. However, dissatisfaction with topicals is common and rates of non-adherence are high. Assessing patients' perspectives can help to identify unmet needs. OBJECTIVE: Our aim was to investigate satisfaction of patients with psoriasis with topical therapy and to determine influencing factors. METHODS: Patients were recruited from the Department of Dermatology, University Medical Center Mannheim, Germany. Satisfaction was assessed using the Treatment Satisfaction Questionnaire for Medication version 1.4 with the domains effectiveness, side effects, convenience, and global satisfaction (scale 0-100 each). The impact of sociodemographic and disease characteristics was determined by multivariate regression. RESULTS: Averaged across the cohort (n = 122, mean age 52.5 years, 58.2% male), the side effects domain had the highest mean satisfaction score (89.7), followed by convenience (72.5), global satisfaction (60.8), and effectiveness (55.0). Comparing specific medications, combinations of corticosteroids and vitamin D analogues were rated best in effectiveness. Treatment satisfaction was influenced by age, partnership, ability to apply topicals independently, disease-related quality-of-life impairment, sole or adjunctive use of topicals and pruritus. CONCLUSIONS: Participants were particularly satisfied with safety but rather dissatisfied with effectiveness of topicals. Topical therapy should be adapted to individual needs with special attention to effectiveness.


Assuntos
Fármacos Dermatológicos , Psoríase , Humanos , Masculino , Pessoa de Meia-Idade , Feminino , Satisfação do Paciente , Fármacos Dermatológicos/efeitos adversos , Psoríase/terapia , Inquéritos e Questionários , Administração Cutânea
4.
Cancers (Basel) ; 16(1)2023 Dec 27.
Artigo em Inglês | MEDLINE | ID: mdl-38201568

RESUMO

BACKGROUND: Primary cutaneous T-cell lymphomas (CTCLs) are rare lymphoproliferative malignancies characterized by significant morbidity and mortality in advanced disease stages. As curative approaches apart from allogeneic stem cell transplantation are lacking, establishing new treatment options, especially combination therapies, is crucial. METHODS: This retrospective study included 11 patients with SS or MF receiving therapy with mogamulizumab in combination with ECP from four European expert centers. The response rates in the skin and blood as well as treatment use and adverse events (AE) were described. RESULTS: 8/11 patients (73%) showed an overall response (OR) in the skin. The mean mSWAT decreased from 98.2 ± 40.8 to 34.6 ± 23.8. The overall response rate (ORR) in the blood was 64% with two complete responses. During combination therapy, the mean number of Sézary cells decreased from 3365.3 × 106/L before treatment to 1268.6 × 106/L. The mean minimum known period without progress was 7.2 months in the skin and 7.6 months in the blood. The most common AEs were mogamulizumab-associated rash (MAR) (45.5%), anemia (27.3%), lymphocytopenia (27.8%), and infusion related reaction (16.7%). No AE led to treatment discontinuation. CONCLUSIONS: Our study presents the combination of mogamulizumab and ECP as an effective therapy in the blood and skin in CTCL with good tolerability, similar to mogamulizumab monotherapy.

5.
J Dermatolog Treat ; 33(5): 2595-2604, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-35373695

RESUMO

BACKGROUND: Topical medication continues to be the most frequently prescribed therapy for psoriasis. However, patients are often dissatisfied with their topical medication, and adherence to this type of therapy is particularly poor. OBJECTIVE: To investigate the preferences of patients with psoriasis regarding the process and outcome attributes associated with topical treatments and to assess influencing factors. METHODS: A discrete choice experiment was conducted to analyze patient preferences for topical psoriasis treatments based on outcome attributes (probabilities of 90% improvement, 50% improvement, skin atrophy and skin irritation) and process attributes (treatment cost not covered by health insurance, treatment duration, location, frequency and formulation). RESULTS: The study cohort (N = 184) considered probabilities of 50% (Relative Importance Score (RIS)=41.0) and 90% (RIS = 33.9) improvement most important, followed by risk of skin atrophy (RIS = 26.4) and treatment cost (RIS = 22.2). Treatment location (RIS = 18.9), risk of skin irritation (RIS = 16.2), treatment frequency (RIS = 13.3) and formulation (RIS = 11.0) were considered less relevant. Income, cardiovascular disease, number of visits and current topical therapy influenced treatment preferences. CONCLUSIONS: Averaged across the cohort, participants preferred an efficient topical treatment associated with a low risk of skin atrophy and reasonable personal expenses. Individual preferences should be integrated into a shared decision-making process about psoriasis treatment.


Assuntos
Doenças Cardiovasculares , Psoríase , Administração Tópica , Atrofia , Humanos , Preferência do Paciente , Psoríase/tratamento farmacológico
6.
Eur J Dermatol ; 31(2): 183-191, 2021 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-33871361

RESUMO

BACKGROUND: COVID-19 poses significant challenges for care of patients with chronic inflammatory skin diseases including psoriasis. OBJECTIVES: To investigate changes in treatment and/or appointments for psoriasis patients in a German university hospital due to the pandemic. MATERIALS & METHODS: A postal survey was conducted between May 15 and June 15, 2020. Potential determinants of changes were analysed with descriptive statistics and multivariate logistic regression. RESULTS: Out of 205 respondents, 19.5% missed an appointment and 9.8% changed therapy due to the pandemic. Treatment alterations were encouraged by patients (50%) and physicians (40%), whereas cancellations of appointments mostly occurred on patients' request (70%). Several patient-related key drivers of changes, including sociodemographic, disease- and health-related characteristics were identified. Changes in treatment and appointments were associated with higher psoriasis severity scores and more frequent disease aggravations. CONCLUSION: It is particularly crucial to tailor psoriasis care to individual needs in order to protect the physical and mental well-being of patients during the pandemic.


Assuntos
Agendamento de Consultas , COVID-19 , Psoríase/terapia , Alemanha , Hospitais Universitários , Humanos
7.
Brain Struct Funct ; 224(8): 2973-2982, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31482268

RESUMO

Affect can directly influence memory storage and retrieval, which offers the opportunity to improve memory performance by changing affective responses. A promising target is the left dorsolateral prefrontal cortex (dlPFC), as it is functionally involved in both affect and memory. This study explores whether anodal transcranial direct current stimulation (tDCS) to the left dlPFC improves memory retrieval through the reduction of negative affect and if this interacts with age. We randomly assigned 94 healthy individuals (n = 43 young, n = 51 elderly) to either sham or active tDCS during encoding of a verbal episodic memory task. Participants completed two questionnaires assessing affective states pre- and post-stimulation. They had to recall items unexpectedly 20 min after encoding and to name which feelings were associated with this free recall. We applied mediation models to explore the relation between tDCS, change in affect, and memory retrieval. In young participants, the reduction of negative affect via anodal tDCS fully mediated the increase in memory retrieval (R2 = 57%; p < 0.001); that is, a stronger reduction of negative affect via tDCS led to better memory performance. We did not observe these effects in the elderly. Our study provides a further link between affect and memory: as increased activity in the dlPFC is crucial for successfully coping with affective interference, anodal tDCS seems to help preventing irrelevant negative thoughts, thus foster attention allocation. Studies applying anodal tDCS to the left dlPFC in healthy young participants should consider changes in affect when interpreting the effect of stimulation on memory performance.


Assuntos
Afeto/fisiologia , Rememoração Mental/fisiologia , Córtex Pré-Frontal/fisiologia , Estimulação Transcraniana por Corrente Contínua , Adulto , Fatores Etários , Idoso , Feminino , Humanos , Masculino , Memória Episódica , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA